2009 and vaccines: lots of activity, and surprises.
1 January 2010, 11:08 am
LONDON, UK—-31st December 2009—-ExpertREACT. 2009 was a year of unprecedented activity for the vaccine industry. Not only did existing players have to mount a rapid response to an influenza pandemic, they also had to ramp up corporate expansion to stay ahead of newcomers. Overall it was a year of many surprises but beyond the H1N1 “blip”, meningitis (now more so B) and the nosocomial segment are still the long-term growth drivers. READ ARTICLE.
2009 and vaccines: lots of activity, and surprises.
LONDON, UK—-31st December 2009—-ExpertREACT. 2009 was a year of unprecedented activity for the vaccine industry. Not only did existing players have to mount a rapid response to an influenza pandemic, they also had to ramp up corporate expansion to stay ahead of newcomers. Overall it was a year of many surprises but beyond the H1N1 “blip”, meningitis (now more so B) and the nosocomial segment are still the long-term growth drivers. READ ARTICLE.